Linda Lennox | Vice President-Investor Relations |
Bill Heiden | President and Chief Executive Officer |
Nik Grund | Chief Commercial Officer |
Ted Myles | Chief Financial Officer |
Julie Krop | Chief Medical Officer |
Eun Yang | Jefferies |
Thomas Smith | Morgan Stanley |
Morgan Williams | Barclays |
Joseph Schwartz | Leerink Partners |
Jessica Fye | JPMorgan |
Serge Belanger | Needham & Company |
Ken Trbovich | Janney |
Kyle Smith | Jefferies |
Good morning. My name is Amy, and I will be your conference operator today. At this time, I would like to welcome everyone to the AMAG Pharmaceuticals Fourth Quarter and Full Year 2017 Earnings Call. All lines have been placed on mute to prevent any background noise. After the speakers’ remarks there will be a question-and-answer session.